Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBUPROFEN LYSINE vs ICODEXTRIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBUPROFEN LYSINE vs ICODEXTRIN: Safety Overview

Metric IBUPROFEN LYSINE ICODEXTRIN
Total FAERS Reports 277 253
Deaths Reported 27 70
Death Rate 9.7% 27.7%
Hospitalizations 110 147
Average Patient Age 12.6 yrs 63.1 yrs
% Female Patients 46.1% 42.7%
FDA Approval Date Apr 13, 2006 Dec 20, 2002
Manufacturer Recordati Rare Diseases Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription Prescription